CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has found more than two of three women taking the drug experienced some type of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback